MicroRNA based method for anti-colorectal cancer effects and prognosis of colorectal cancer
AssigneeKaohsiung Medical University
InventorsSuh-Hang Hank Juo, Jaw-Yuan Wang, I-Ping Yang, Hsiang-Lin Tsai
Life of this patent
Estimating the term…
Abstract
The present invention discloses a method of providing anti-oncogenic effects in a subject suffered from colorectal cancer. The present invention also discloses a method for screening an anti-colorectal cancer agent. The present invention further discloses a method of determining the prognosis of a subject with colorectal cancer.
Claims5
A method of determining the prognosis of a subject with colorectal cancer, comprising measuring the level of miR-93 in a test sample from said subject, wherein a decrease in the level of miR-93 in the test sample, relative to the level of miR-93 in a control sample, is indicative of predicting early recurrence of colorectal cancer.
Dependencies are inferred from the claim text.